|
|
||||||||
Chemistry Department, Brookhaven National Laboratory, Upton, NY
Correspondence: For reprints contact: Robert R. MacGregor, MD, Chemistry Department, Brookhaven National Laboratory, Upton, NY 11973.
ABSTRACT
High specific activity [18F]N-methylspiroperidol(8-[4-(4-[18F]fluorophenyl)-4-oxobutyl]-3-methyl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one, 510 mCi/ml, 48 Ci/µmol at EOB) in saline solution undergoes significant radiolytic decomposition resulting in a decrease in radiochemical purity of 1025% during the first hour. The rate of decomposition is affected by the specific activity, total dose to and chemical composition of the solution. That radiolysis is responsible for the observed decomposition was verified by the observation that unlabeled N-methylspiroperidol is decomposed in the presence of [18F]fluoride.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |